| BTK | Bruton Tyrosine Kinase |
| CI | Comorbidity Index |
| CLL | Chronic Lymphocytic Leukemia |
| DDI | Drug–Drug Interaction |
| EFS | Event-Free Survival |
| OS | Overall Survival |
| PFS | Progression-Free Survival |
| BTK | Bruton Tyrosine Kinase |
| CI | Comorbidity Index |
| CLL | Chronic Lymphocytic Leukemia |
| DDI | Drug–Drug Interaction |
| EFS | Event-Free Survival |
| OS | Overall Survival |
| PFS | Progression-Free Survival |